Clinical Trials for Alcresta Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alcresta Therapeutics

Clinical Trials (4)

NCT05710315
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
NARecruiting
32 participants
Started: May 7, 2025 · Completed: Mar 2, 2026
2 conditions2 sponsors1 location
NCT06691893
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
PHASE3Recruiting
60 participants
Started: Mar 28, 2025 · Completed: Jul 15, 2027
2 conditions2 sponsors1 location
NCT05635747
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
N/AEnrolling by invitation
32 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
2 conditions2 sponsors1 location
NCT03530852
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NARecruiting
32 participants
Started: Nov 21, 2018 · Completed: Sep 30, 2028
2 conditions2 sponsors1 location